Submitted by Anonymous (not verified) on 28 March 2025 - 14:40
Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Date of authorisation: 23/06/2017, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Date of authorisation: 23/06/2017, Revision: 15, Status: Authorised